Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
SHARE NOW
Thursday, June 13, 2024 | 08:00 [PDT] | 11:00 [EDT] | 16:00 [BST]
WATCH ON DEMAND | MEET THE PANEL
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
The EV therapy market shows significant potential for treating diverse medical conditions, with regenerative and immunomodulatory properties fueling optimism for therapeutic applications. However, large-scale manufacturing, low affinity, quantification, and standardization remain challenges. This webinar will address these issues and demonstrate how Univercells Technologies’ solutions can help.
What to Expect:
Part 1: Tackling EV Manufacturing Challenges
Discover obstacles to unlocking EVs’ full therapeutic potential.
- Explore the scale-X fixed-bed bioreactor technology.
- Understand the benefits of production in perfusion and the concentration of EVs using integrated Tangential Flow Filtration (TFF), ensuring EVs consistently meet quality criteria.
Part 2: Real-World Success Stories
Discover obstacles to unlocking EVs’ full therapeutic potential.
- Learn from case studies where organizations like Rooster Bio used scale-X bioreactors.
- See how scale-X bioreactors increase EV productivity and meet quality criteria.
Part 3: Interactive Q&A
Discover obstacles to unlocking EVs’ full therapeutic potential.
- Get your questions answered by our technology expert.
Key Takeaways:
- Overcome challenges with traditional manufacturing systems.
- Discover the scale-X bioreactors’ scalable, continuous, and high-capacity manufacturing.
- Achieve up to a 2-fold increase in EV productivity while maintaining quality.
- Explore optimization strategies for yield, purity, and scalability.
Join us to learn how Univercells Technologies’ fixed-bed design is revolutionizing EV production for more efficient and high-quality therapeutic applications.
This webinar is brought to you in partnership with Univercells Technologies by Donaldson.